Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax for Prevention of Differentiation Syndrome in APL
NCT06544109Phase 3Enrolling by invitation
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venetoclax in differentiation syndrome (DS), sponsored by First Affiliated Hospital of Soochow University. Started Aug 2023; status: enrolling by invitation.
02
Drugs
venetoclax
03
Conditions
differentiation syndrome (DS)
Beyond the preview
Go deeper on NCT06544109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06544109.